Pregnancy Experience: Nonclinical Studies and Pregnancy Outcomes in the Daclizumab Clinical Study Program

INTRODUCTION: Multiple sclerosis (MS) is more common in women and can occur during childbearing years; thus, information on outcomes following exposure to MS therapy during pregnancy is important. No formal studies of daclizumab have been conducted in pregnant women. Here, we report available noncli...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Ralf, Stefoski, Dusan, Selmaj, Krzysztof, Havrdova, Eva, Hurst, Christopher, Holman, Joan, Tornesi, Belen, Akella, Surekha, McCroskery, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130915/
https://www.ncbi.nlm.nih.gov/pubmed/27411694
http://dx.doi.org/10.1007/s40120-016-0048-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130915/
https://www.ncbi.nlm.nih.gov/pubmed/27411694
http://dx.doi.org/10.1007/s40120-016-0048-2

Ejemplares similares